Clinical Data Management White Paper & Articles

  1. The Budget Line Item That Could Make Or Break Retention 6/16/2026

    A participant's preferred payment method can make or break retention. Learn how flexible, participant-friendly compensation benefits both study volunteers and trial success.

  2. What Is Ontology? Learn About The Data Layer That Makes Agentic AI Work 6/3/2026

     Get an overview of ontology, the "semantic translator" that determines whether your AI investments actually compound or stay forever siloed.

  3. Advantages Of Integrated Clinical Trial Management 5/28/2026

    Disconnected trial systems slow sites and patients. Centralizing logistics, payments, and data improves visibility, reduces admin work, and keeps enrollment on track for more patient‑focused studies.

  4. Pay-By-Procedure Or Pay-By-Visit: Which Model Fits Your Trial? 5/28/2026

    Site payment models shape trial cost and execution. Compare visit‑based simplicity vs procedure‑level precision to see when flexibility and savings beat complexity — or when predictability wins.

     

  5. The New Reality Of Clinical Trial Payment 5/28/2026

    Modern trials need financial workflows that match their complexity — align payments to procedures, centralize spend, and reduce delays to protect cash flow, support patients, and improve execution.

  6. 2026 Life Sciences Trends 5/15/2026

    Life sciences leaders in 2026 need more than breakthrough science. Build operational clarity, scalable systems, and investor-ready visibility to support growth, funding, and execution.

  7. IRT vs. RTSM: What Sponsors Need To Know When Choosing Clinical Trial Technology 5/6/2026

    Mastering the nuances between IRT and RTSM allows trial teams to move past confusing jargon and focus on the supply intelligence and randomization logic essential for study integrity.

  8. What The Joint FDA And EMA's AI Principles Can Mean For Clinical Trial Technology 5/6/2026

    New FDA/EMA principles align global expectations for AI in drug trials, emphasizing transparency, human-centric design, and risk-based governance to ensure data integrity and patient safety.

  9. General Wellness Isn't A Vibe Anymore: What The 2026 FDA Update Means 4/6/2026

    The FDA’s 2026 guidance has put an end to "wellness by disclaimer." Learn how new standards for wearables and apps impact study design, participant safety, and the evolving ethical role of the IRB.

  10. Bringing Local Payments To International Clinical Trials 3/18/2026

    Replace slow international wires with local digital payments, reduce participant friction, and ensure fair, instant reimbursements across the globe.